Synthesis, characterization and in vitro antimicrobial activity of novel sulfonylureas of 15-membered azalides

Journal of Antibiotics

Volumn 58, Issue 6, 2005, Pages 380-389

  Krajačíc, Mirjana Bukvić ^a   Kujundžić, Nedjeljko ^a   Dumić, Miljenko ^a   Cindrić, Mario ^a   Brajša, Karmen ^a   Metelko, Biserka ^a   Novak, Predrag ^a  

^a PLIVA CROATIA LTD   (Croatia)

Author keywords

Antimicrobial activity; Azalides; NMR and MS; Sulfonylurea; Synthesis

Indexed keywords

5 O DESOSAMINYL 9 DEOXO 9 DIHYDRO 9A AZA 9A HOMOERYTHRONOLIDE A; 5 O DESOSAMINYL 9 DEOXO 9 DIHYDRO 9A N [N' (PHENYLSULFONYL)CARBAMOYL] 9A AZA 9A HOMOERYTHRONOLIDE A; 9 DEOXO 9 DIHYDRO 9A AZA 9A HOMOERYTHROMYCIN; 9 DEOXO 9 DIHYDRO 9A N [N' (BETA CYANOETHYL) N' (PHENYLSULFONYL)CARBAMOYL GAMMA AMINOPROPYL] 9A AZA 9A HOMOERYTHROMYCIN A; 9 DEOXO 9 DIHYDRO 9A N [N' (PHENYLSULFONYL)CARBAMOYL GAMMA AMINOPROPYL] 9A AZA 9A HOMOERYTHROMYCIN A; 9 DEOXO 9 DIHYDRO 9A N [N' (PHENYLSULFONYL)CARBAMOYL] 9A AZA 9A HOMOERYTHROMYCIN A; ANTIBIOTIC AGENT; AZALIDE; AZITHROMYCIN; MACROLIDE; SULFONYLUREA DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; DRUG STRUCTURE; DRUG SYNTHESIS; ELECTROSPRAY MASS SPECTROMETRY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; STREPTOCOCCUS PYOGENES;

NEGIBACTERIA; POSIBACTERIA; STREPTOCOCCUS PYOGENES;

EID: 22444445360     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.1038/ja.2005.48     Document Type: Article

References (23)

1. Iacoviello VR, Zinner SH. Macrolides: a clinical overview, In: Schönfeld W, Kirst HA. (Eds.): Macrolide Antibiotics, Birkhäuser Verlag, Basel, pp. 15-24 (2002)
2. Kirst HA. Expanding the Role of Macrolide Compounds as Terapeutic Agent, Progress in Medicinal Chemistry, Harwood Academic Publisher (1997)
3. Girard AE, Girard D, English AR, Gotz TD, Cimochowski CR, Faiella JA, Haskell SL, Retsema JA. Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half life and excellent tissue distribution. Antimicrob Agent Chemother 31: 1948-1954 (1987)
4. Schonwald S, Skerk V, Petricevic I, Cart V, Majerus-Misic L, Gunjaca M. Comparison of three-day and five-day courses of azithromycin in the treatment of atypical pneumonia. Eur J Clin Microbiol Infect Dis 10: 877-880 (1991)
5. Retsema J, Girard A, Schelkly W, Manousos M, Anderson M, Bright G, Borovoy R, Brenan L, Manson R. Spectrum and mode of action of azythromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against Gram-negative organisms. Antimicrob Agent Chemother 31: 1939-1947 (1987)
6. Prieto J, Calvo A, Gómez-Lus ML. Antimicrobial resistance: a class effect? J Antimicrob Chemother 50 (Suppl S2): 7-12 (2002)
7. Cunningham MW: Pathogenesis of Group A streptococcal infections. Clin Microbiol Reviews 13: 470-511 (2000)
8. Granizo JJ, Aguilar L, Casal J, Dal-Ré R, Baquero F. Streptococcus pyogenes resistance to erythromycin in relation to macrolide consumption in Spain (1986-1997). J Antimicrob Chemother 46: 959-964 (2000)
9. Szczypa K, Sadowy E, Izdebski R, Hryniewicz W. A rapid increase in macrolide resistance in Streptococcus pyogenes isolated in Poland during 1996-2002. J Antimicrob Chemother 54: 828-831 (2004)
10. Nagai K, Appelbaum PC, Davies TA, Kelly LM, Hoellman DB, Tambic Andrasevic A, Drukalska L, Hryniewicz W, Jacobs MR, Kolman J, Miciuleviciene J, Pana M, Setchanova L, Konkoly Thege M, Hupkova H, Trupl J, Urbaskova P. Susceptibility to telithromycin in 1,011 Streptococcus pyogenes isolates from 10 Central and Eastern European Countries. Antimicrob Agents Chemother 46 (2): 546-549 (2002)
11. Albrich WC, Monnet DL, Harbarth S. Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes. Emerg Infect Dis 10 (3): 514-517 (2004)
12. Nakajima Y. Mechanisms of bacterial resistance to macrolide antibiotics. J Infec Chemother 5: 61-74 (1999)
13. Poehlsgarrd J, Douthwaite S. Macrolide antibiotic interaction and resistance on the bacterial ribosome. Curr Opin Invest Drugs 4: 140-144 (2003)
14. Weisblum B. Macrolide resistance. Drug Resistance Updates 1: 29-41 (1998)
15. Sutcliffe J, Tait-Kamradt A, Wondrack L. Streptococcus pneumoniae and Streptococcus pyogenes resistant to macrolides but sensitive to clindamycin: a common resistance pattern mediated by an efflux system. Antimicrob Agents Chemother 40: 1817-1824 (1996)
16. Dokic S, Kobrehel G, Lazarevski G, Lopotar N, Tamburasev Z, Kamenar B, Nagl A, Vickovic I. Erythromycin series. Part 11. Ring expansion of erythromycin A oxime by the Beckmann rearrangement. J Chem Soc Perkin Trans I: 1881-1890 (1986)
17. Dokić S, Kobrehel G, Lopotar N, Kamenar B, Nagl A, Mrvoš D. Erythromycin series. Part 13. Synthesis and structure elucidation of 10-dihydro-10-deoxo-11-methyl-11-azaerythromycin A. J Chem Research (S), 152-153 (1988);
18. Dokić S, Kobrehel G, Lopotar N, Kamenar B, Nagl A, Mrvoš D. Erythromycin series. Part 13. Synthesis and structure elucidation of 10-dihydro-10-deoxo-11-methyl-11-azaerythromycin A. J Chem Research (S), ibid., Miniprint, 1239-1257 (1988)
19. Schönfeld W, Mutak S. Azithromycin and Novel Azalides, In: Schönfeld W, Kirst HA. (Eds.): Macrolide Antibiotics, Birkhäuser Verlag, Basel, 73-95 (2002).
20. Bright GM, Nagel AA, Bordner J, Watrous KA, Sciavolino FC, English AR, Retsema JA, Anderson MR, Brennan LA, Borovoy RJ, Cimochowski CR, Faiella JA, Girard AE, Girard D, Herbert C, Manousos M, Mason R. Synthesis, in vitro and in vivo activity of novel 9-deoxo-9a-aza-9a-homoerythromycin A derivatives; a new class of macrolide antibiotics, the azalides. J Antibiot 41: 1029 (1988)
21. Kujundzic N, Kobrehel G, Banić Z, Kelnerić, Kojić-Prodić B. Azalides: Synthesis and antibacterial activity of novel 9a-N-(N′-substituted carbamoyl and thiocarbamoyl) derivatives of 9-deoxo-9a-aza-9a-homoerythromycin A. Eur J Med Chem 30: 455-462 (1995)
22. Sheldrick GM, Kojić-Prodić B, Banić Z, Kobrehel G, Kujundžić N. Structure of 9-deoxo-9a-N-(N′-(4′- pyridyl)-carbamoyl)-9a-aza-9a-homoerythromycin A and conformational analysis of analogous 9a-aza 15-membered azalides in solid state. Acta Cryst B51 358-366 (1995)
23. LeMahieu RA, Carson M, Kierstead W. Glycoside cleavage reactions on erythromycin A. Preparation of erythronolide A. J Med Chem 17: 953 (1974)